Liverpool Head and Neck Centre, School of Health Science, University of Liverpool, United Kingdom.
Population Health Sciences Institute, Newcastle University Centre for Cancer, Newcastle University, United Kingdom.
Oral Oncol. 2021 Jul;118:105344. doi: 10.1016/j.oraloncology.2021.105344. Epub 2021 May 20.
To investigate the recovery trajectory and predictors of outcome for swallowing difficulties following head and neck cancer treatment in a large prospective cohort.
Data from 5404 participants of the Head and Neck 5000 study were collected from 2011 to 2014. Patient-reported swallowing was measured using the EORTC HN35, recorded at baseline (pre-treatment) and 4 and 12 months post-baseline. Mixed-effects linear multivariable regression was used to investigate time trends, compare cancer sites, and identify associations between clinical, socio-demographic and lifestyle variables.
2458 participants with non-recurrent oral (29%) oropharyngeal (46%) and laryngeal (25%) cancer were included in the analysis. There was a clinically significant deterioration in scores between baseline and four months for swallowing (11.7 points; 95% CI 10.7-12.8) and trouble with social eating (17.9 points; 95% CI 16.7-19.2), but minimal difference between baseline and 12 months. Predictors of better swallowing and social eating were participants with larynx cancer, early-stage disease, treatment type, age, gender, co-morbidity, socio-economic status, smoking behaviour and cohabitation.
Swallowing problems persist up to a year after head and neck cancer treatment. These findings identify disease and demographic characteristics for particularly vulnerable groups, supporting the need for holistic interventions to help improve swallowing outcomes. People diagnosed with head and neck cancer at risk of severe eating and drinking problems following treatment can be identified earlier in the pathway, receive more accurate information about early and late post-treatment side-effects, which can inform shared decision-making discussions.
在一项大型前瞻性队列研究中,调查头颈部癌症治疗后吞咽困难的恢复轨迹和结局预测因素。
2011 年至 2014 年期间,收集了来自 Head and Neck 5000 研究的 5404 名参与者的数据。采用 EORTC HN35 量表评估患者报告的吞咽功能,在基线(治疗前)和基线后 4 个月和 12 个月进行记录。采用混合效应线性多变量回归分析来调查时间趋势、比较癌症部位,并确定临床、社会人口统计学和生活方式变量之间的关联。
共纳入 2458 名非复发性口腔(29%)、口咽(46%)和喉(25%)癌症患者。吞咽(11.7 分;95%CI 10.7-12.8)和社交进食困难(17.9 分;95%CI 16.7-19.2)评分在基线和 4 个月之间出现了具有临床意义的恶化,但在基线和 12 个月之间差异较小。吞咽和社交进食功能更好的预测因素为患有喉癌、疾病早期、治疗类型、年龄、性别、合并症、社会经济地位、吸烟行为和同居。
头颈部癌症治疗后吞咽问题可持续长达 1 年。这些发现确定了疾病和人口统计学特征,为特别脆弱的群体提供了支持,需要进行整体干预,以帮助改善吞咽结局。可以在治疗前更早地识别出有严重饮食和饮水问题风险的头颈部癌症患者,为他们提供更准确的关于治疗前后早期和晚期副作用的信息,这有助于进行共同决策讨论。